Yosuke Okada Selected Research

Yosuke Okada Research Topics

Disease

60	Type 2 Diabetes Mellitus (MODY) 04/2022 - 06/2005
22	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 02/2006
15	Atherosclerosis 09/2021 - 05/2003
14	Neoplasms (Cancer) 03/2022 - 07/2004
12	Hyperglycemia 01/2021 - 06/2005
12	Osteoporosis 01/2018 - 06/2003
10	Bone Resorption 01/2021 - 08/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2017
9	Hypercalcemia (Milk Alkali Syndrome) 10/2020 - 06/2003
8	Diabetes Mellitus 09/2021 - 06/2006
7	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 01/2004
7	Vascular Calcification 01/2019 - 08/2006
6	Hyperemia 02/2022 - 01/2020
6	Insulin Resistance 01/2019 - 01/2006
6	Graves Disease (Basedow Disease) 01/2017 - 01/2014
5	Body Weight (Weight, Body) 01/2022 - 10/2008
4	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2012
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2021 - 01/2015
4	Hypertension (High Blood Pressure) 01/2021 - 07/2012
4	Insulinoma 05/2020 - 02/2006
4	Bone Fractures (Bone Fracture) 11/2019 - 06/2003
4	Hypophosphatemia 02/2019 - 01/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2022 - 04/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2021
3	Multiple Myeloma 01/2022 - 01/2019
3	Glucose Intolerance 01/2022 - 10/2008
3	Diabetic Angiopathies (Diabetic Angiopathy) 04/2021 - 12/2006
3	Heart Failure 01/2021 - 04/2017
3	Thyroiditis 01/2021 - 09/2003
3	Hypothyroidism 01/2021 - 12/2002
3	Osteomalacia 10/2020 - 01/2012
3	Hyperparathyroidism 10/2020 - 04/2004
3	Chronic Renal Insufficiency 01/2020 - 07/2012
3	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 06/2005
2	Hepatoblastoma 03/2022 - 03/2022
2	Leukemia 03/2022 - 02/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2022 - 01/2022
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Overweight 01/2022 - 01/2006
2	Disease Progression 01/2022 - 01/2012

Drug/Important Bio-Agent (IBA)

45	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2006
17	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2013
12	Diphosphonates (Bisphosphonates)IBA 11/2016 - 11/2002
11	Insulin (Novolin)FDA Link 04/2022 - 06/2005
10	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2021 - 01/2017
9	GlucocorticoidsIBA 11/2016 - 06/2003
8	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 11/2008
8	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 12/2012
7	Hemoglobins (Hemoglobin)IBA 04/2022 - 05/2014
6	Vitamin D FDA LinkGeneric 02/2022 - 12/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 06/2005
6	AlbuminsIBA 04/2021 - 12/2006
6	Sodium-Glucose Transport ProteinsIBA 01/2021 - 04/2017
6	CalciumIBA 02/2019 - 07/2004
6	voglibose (Basen)IBA 06/2018 - 02/2006
6	LipidsIBA 04/2018 - 10/2008
6	CytokinesIBA 01/2018 - 07/2004
5	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 09/2021 - 10/2017
5	SodiumIBA 09/2021 - 01/2014
5	CholesterolIBA 01/2021 - 12/2006
5	empagliflozinIBA 01/2021 - 04/2017
5	oxidized low density lipoproteinIBA 03/2018 - 05/2003
4	Triglycerides (Triacylglycerol)IBA 04/2022 - 12/2006
4	hydroxide ionIBA 02/2022 - 08/2002
4	alogliptinIBA 01/2021 - 07/2013
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 09/2013
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 02/2017
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 12/2016
4	Parathyroid Hormone (Parathormone)IBA 10/2020 - 04/2004
4	Fibroblast Growth Factor-23IBA 10/2020 - 01/2012
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2020 - 05/2014
4	LinagliptinIBA 06/2018 - 11/2016
4	alfacalcidolIBA 11/2016 - 01/2004
4	Etidronic Acid (HEDP)FDA LinkGeneric 01/2012 - 01/2004
3	CreatinineIBA 04/2021 - 01/2012
3	AutoantibodiesIBA 02/2021 - 12/2002
3	AntigensIBA 01/2021 - 08/2002
3	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2021 - 03/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 09/2013
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2020 - 03/2015
3	dapagliflozinIBA 01/2020 - 06/2016
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2015
3	ipragliflozinIBA 01/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 11/2007
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 05/2014
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2017 - 02/2006
3	AdiponectinIBA 07/2012 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 06/2005
2	Methylprednisolone FDA LinkGeneric 03/2022 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 06/2006
2	AntibodiesIBA 01/2022 - 01/2018
2	Biological ProductsIBA 01/2022 - 02/2006

Therapy/Procedure

31	Therapeutics 01/2022 - 01/2004
10	Glycemic Control 02/2019 - 06/2006
5	Aftercare (After-Treatment) 04/2020 - 01/2014
4	Drug Therapy (Chemotherapy) 03/2022 - 07/2004
3	Transplantation 02/2022 - 01/2021
3	Cell Transplantation 01/2022 - 01/2022
3	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2022